Feasibility of 123I-IBZM Scintigraphy (a D2 Agonist) in Patients With Pheochromocytoma (PHEO) and/or Paraganglioma (PGL) : Study Pilot
Clinical trial NCT00875407 · COMPLETED
Trial details
- NCT number
- NCT00875407
- Sponsor
- Assistance Publique Hopitaux De Marseille
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2009-02-01
- Primary completion
- 2012-07-01
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.